BC
ELV icon

Bridgefront Capital’s Elevance Health ELV Stock Holding History

Bridgefront Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.36M Buy
+4,632
New +$1.52M 0.34% 80
2025
Q4 		– Sell
-1,905
Closed -$616K – 597
2025
Q3 		$616K Buy
+1,905
New +$592K 0.18% 189
2024
Q4 		– Sell
-632
Closed -$329K – 637
2024
Q3 		$329K Buy
+632
New +$338K 0.13% 294
2023
Q3 		– Sell
-1,702
Closed -$756K – 448
2023
Q2 		$756K Buy
1,702
+606
+55% +$280K 0.41% 48
2023
Q1 		$504K Buy
+1,096
New +$522K 0.31% 104

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Bridgefront Capital's ELV Position: Q1 2026 in Review

Bridgefront Capital opened a new position in Elevance Health (ELV) in Q1 2026: 4,632 shares worth $1.36M. The stake represents 0.34% of the portfolio and ranks #80 among its holdings. This is a return to the name: Bridgefront Capital previously reported a position in ELV as recently as Q3 2025.

Bridgefront Capital first reported a position in ELV in Q1 2023 and has held it in 5 quarters since. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Bridgefront Capital held 4,632 shares of Elevance Health worth $1.36M as of Q1 2026.
  • Elevance Health was a new Bridgefront Capital position in Q1 2026.
  • Elevance Health made up 0.34% of Bridgefront Capital's portfolio in Q1 2026, its #80 holding.
  • Bridgefront Capital first reported a position in Elevance Health in Q1 2023 and has held it in 5 quarters since.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Bridgefront Capital's 13F filing for Q1 2026, filed 15 May 2026.